anti-Annexin A1 (human), Rabbit Monoclonal (RM424)

Product description: The annexin superfamily consists of 13 calcium or calcium and phospholipid binding proteins with high biological and structural homology. Annexin-1 (ANXA1) is the first characterized member of the annexin family of proteins and is able to bind to cellular membranes in a calcium-dependent manner, promoting membrane fusion and endocytosis. Loss of function or expression of this gene has been detected in multiple tumors. Annexin A1 has anti-inflammatory properties and inhibits phospholipase A2 activity, can accumulate on internalized vesicles after EGF-stimulated endocytosis and may be required for a late stage in inward vesiculation. Annexin A1 has also been identified as one of the 'eat-me' signals on apoptotic cells that are to be recognized and ingested by phagocytes. Annexin A1, as an endogenous anti-inflammatory mediator, has roles in many diverse cellular functions, such as membrane aggregation, inflammation, phagocytosis, proliferation, apoptosis and tumorigenesis and cancer development.

Alternate Names/Synonyms: Lipocortin-1; p35; Annexin-1; Calpactin-2; Calpactin II; Lipocortin I; Chromobindin-9; Phospholipase A2 Inhibitory Protein

Product Type: Recombinant Antibody

Clone: RM424

Isotype: Rabbit IgG

Immunogen: A peptide corresponding to the N-terminus of human Annexin A1.

Applications: IHC, WB

Species Crossreactivity: Human

Specificity: RM424 reacts to human Annexin A1.

Concentration: N/A

Long Term Storage: -20°C

Shipping: BLUE ICE

Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.

Lien vers la Fiche Technique